Home

HAROLD E SELICK

CIK 1287233 · Chief Executive Officer · last filed 2026-03-27

HAROLD E SELICK is a Chief Executive Officer who has filed 64 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for PTGX, was dated Mar 27, 2026. Across all open-market trades the lifetime net is −$2.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $8.9M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$8.91M

Companies

6

Total Filings

64

Lifetime Open-Market Net

-$2.16M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PTGX Director 60,845 $146.49 $8.91M -$2.44M 18 2026-03-27
Molecular Templates, Inc. (MTEM) Delisted Director — $0.00 — $0 8 2024-09-30
PDL BIOPHARMA, INC. (PDLI) Delisted Director 256,828 — — $48.5K 11 2019-06-24
CBIO Director — $17.93 — $0 5 2018-01-18
Molecular Templates, Inc. (THLD) Delisted Chief Executive Officer 41,217 — — $229.8K 18 2016-03-15
Molecular Templates, Inc. (THLDD) Delisted Chief Executive Officer 239,480 — — $0 2 2008-09-05

Recent Filings

64 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-03-27 PTGX Mixed — -$2.21M EDGAR
2026-03-26 PTGX Notice (144) −24,000 -$2.52M EDGAR
2026-01-13 PTGX Exer (M) +14,299 $60.2K EDGAR
2026-01-06 PTGX Grant (A) +2,695 $0 EDGAR
2025-04-30 PTGX Exer (M) +10,725 $12.4K EDGAR
2025-01-06 PTGX Grant (A) +5,130 $0 EDGAR
2024-09-30 Molecular Templates, Inc. (MTEM) Delisted Grant (A) — $0 EDGAR
2024-03-11 PTGX Exer (M) +6,490 $12.3K EDGAR
2024-01-04 PTGX Grant (A) — $0 EDGAR
2023-10-31 Molecular Templates, Inc. (MTEM) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 64
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.